Biostage (fka Harvard Apparatus Regenerative Technology, HART) (NASDAQ: BSTG)

Bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea .

Get a Demo and See the Full Profile

Get a demo today to see profiles of Biostage (fka Harvard Apparatus Regenerative Technology, HART) (NASDAQ: BSTG) plus 5959 other startups.

Learn More About Biostage (fka Harvard Apparatus Regenerative Technology, HART) (NASDAQ: BSTG)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More